search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SUPPLEMENT


AI: A STRATEGIC IMPERATIVE FOR PHARMACEUTICAL SUPPLY CHAINS, NEW REPORT FINDS


A


new report commissioned by LogiPharma, has revealed the growing impact of artificial intelligence (AI) and machine


learning (ML) on pharmaceutical supply


chains, highlighting AI’s shift from a “nice-to-have” to a strategic necessity for the industry.


The 2024 LogiPharma AI Report, based on a survey of 100


European life sciences supply chain leaders, demonstrates that AI is rapidly becoming a central component in driving efficiency, resilience and operational excellence across pharmaceutical supply chains. According to the report, over half of respondents expect a return on investment (ROI) from AI and ML initiatives within two to three years, underscoring the sector’s confidence in the technology’s potential. “Our conference delegates and partners consistently tell


us that AI is transforming how they approach supply chain challenges,”


said Will Robinson, Conference Director of


LogiPharma. “AI is no longer just a tool for efficiency - it’s becoming a core enabler for pharmaceutical companies striving to meet the demands of a complex, fast-evolving market.” The report highlights several key areas where AI is making


an impact. It is playing a pivotal role in optimising inventory management, with 40% of companies prioritising AI for demand


forecasting and minimising waste, particularly for temperature- sensitive products like biologics and vaccines. Additionally, 69% of pharmaceutical companies have implemented AI-driven automated alerts to monitor cold chain logistics in real time, ensuring


temperature-sensitive products are transported


safely and effectively. But, whilst AI offers solutions to challenges like inventory


optimisation and supply chain visibility, the journey is not without obstacles. Data integration remains a significant hurdle, as many companies struggle with real-time visibility across fragmented systems and partner networks. Only 11 - 25% of supply chain partners are currently using AI-driven processes, indicating that while the benefits of an interconnected, AI-enabled ecosystem are evident, broader adoption is needed for full impact. “Without data, there is no AI. This fact is particularly impactful


for supply chains, which operate in a state of perpetual change and are always dependent on partners to co-execute shared business processes,” said Shabbir Dahod President and CEO, TraceLink. “Given that a supply chain is only as strong as its weakest link,


the overriding challenge for executives who hope to deploy an AI-driven supply chain strategy is clear: digital networks of end- to-end supply chain partners must be established to source the


real time data required for supply chain process orchestration.” The report also stresses the importance of AI in digital


transformation, with 44% of respondents focusing on AI-powered Sales and Operations Planning (S&OP) to enhance agility in response to market fluctuations and regulatory changes. Director of Operations EMEA/EE, Stefano Chiei at Advanced


Bionics, Sonova Holding commented, “AI is not reinventing the wheel but offering new solutions for efficiency and helping the industry unlock new opportunities.” Day two of the event in Lyon, running from April 8th – 10th,


2025, will feature a dedicated AI Focus Day. This special session will


showcase keynote presentations studies from leading organisations, and case including Sanofi, GSK,


J&J, BioMérieux, and MSD. Attendees can also participate in interactive sessions exploring the practical applications of AI and machine learning in areas such as planning, procurement, network transformation, transport management, and workflow optimisation. The day promises to deliver a thorough overview of cutting-edge advancements and real-world use cases of AI within the pharmaceutical supply chain. LogiPharma’s AI report is available for free download at: https://tinyurl.com/bdd7rtp3


About LogiPharma LogiPharma is the largest global end-to-end supply chain event for life sciences supply chain leaders, their teams and service partners. LogiPharma is the only supply chain event with representation from the top global pharma companies. Through interactive discussions and debates, learn practical solutions to optimise your supply chain value, visibility, flexibility and deliver a customer-first experience whilst saving costs, reducing risk, and remaining compliant.


For media enquiries, please contact Nielsen McAllister on +44 (0) 1332 293939 or email logipharma@nmpr.co.uk


7


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16